ESMO Breast 2020

23–24 May 2021 | Virtual Meeting

The ESMO Breast Cancer Virtual Meeting took place on 23 – 24 May 2020. Experts in the field came together online to present the latest practice-changing data in breast cancer.

Hot topics at this year’s meeting included the rise of precision medicine, immunotherapy, and biomarkers. Updates from the latest clinical trials were received, including data from the CLEOPATRA, IMpassion130 and GELATO studies.

View all videos

ESMO Breast 2020

23–24 May 2021 | Virtual Meeting

The ESMO Breast Cancer Virtual Meeting took place on 23 – 24 May 2020. Experts in the field came together online to present the latest practice-changing data in breast cancer.

Hot topics at this year’s meeting included the rise of precision medicine, immunotherapy, and biomarkers. Updates from the latest clinical trials were received, including data from the CLEOPATRA, IMpassion130 and GELATO studies.

View all videos

Highlights

View all
4:11
Immunotherapy for TNBC: IMpassion130 & KEYNOTE-355
Sara Tolaney • 19 May 2020
2:53
Neoadjuvant chemoimmunotherapy: KEYNOTE-522, I-SPY & more
Marleen Kok • 7 May 2020
3:53
GELATO: carboplatin and atezolizumab in advanced lobular BC
Leonie Voorwerk • 14 May 2020
2:43
CLEOPATRA & EMILIA: HER2+ mBC state-of-the-art
Sandra Swain • 7 May 2020

HER2+ Updates

View all
1:56
NSABP B-41: genes and signatures associated with pCR
Sandra Swain • 7 May 2020
3:22
HER2 blockade in HER2-E induces low-proliferative luminal A phenotype
Aleix Prat • 14 May 2020
2:49
HER2-E pCR with anti-HER2-based neoadjuvant therapies
Aleix Prat • 18 May 2020

TNBC Updates

View all
4:19
The gut microbiome & triple negative breast cancer
Grazia Vernaci • 14 May 2020
4:11
Immunotherapy for TNBC: IMpassion130 & KEYNOTE-355
Sara Tolaney • 19 May 2020

Metastatic Disease Updates

View all
2:10
Targeting low HER2 expression with antibody-drug conjugates
Giuseppe Curigliano • 19 May 2020
5:45
Real-world: efficacy of everolimus + exemestane HR+, HER2- BC
Michael Gnant • 14 May 2020

Genomics

View all
4:21
EMBRACA & OlympiAD: targeting DNA repair
Jennifer Litton • 7 May 2020
7:04
Mismatch repair protein loss in breast cancer
Nicola Fusco • 20 May 2020

Biomarkers

View all
2:03
mTNBC: tumor mutational burden & PTEN Alterations as molecular correlates
Sara Tolaney • 14 May 2020
2:49
HER2-E pCR with anti-HER2-based neoadjuvant therapies
Aleix Prat • 18 May 2020

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals